{"originalText": "，缘于3月前（2014-11-18）因食管癌于我院行“胸腹腔镜联合翻身三切口全胸段食管切除+食管-胃底右颈吻合+空肠造瘘术”。手术顺利，术后恢复良好后出院。术后病理（201441090），：（食管及胃底），：食管隆起型鳞状细胞癌II级，伴坏死，癌组织侵犯脉管及神经组织，脉管内见癌栓，侵及外膜层。手术标本下切端、上切端均未见癌浸润。找到食管周淋巴结1/2个，胃周淋巴结0/2个，及另送（下段食管旁）淋巴结0/1个，（上段食管旁）淋巴结0/3个，（左喉返旁神经）淋巴结0/4个，（第7组）淋巴结0/8个，（第8组）淋巴结0/2个见癌转移。，免疫组化染色结果：KI67（40%阳性），P53（++），P170（-），GSTπ（++），EGFR（+++）。于2014.12.24、2015.01.14按“洛铂50MGD1+氟尿嘧啶4000MGCIV44H”方案行术后2周期化疗，并辅予保肝、止呕、制酸、增强免疫等辅助治疗。现为求化疗求诊我科，门诊拟“食管上段鳞癌术后”收入院。术后至今偶有返酸，进食半流质尚顺畅。饮食睡眠较好。大小便正常。体重无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 19, "end_pos": 22}, {"label_type": "手术", "overlap": 0, "start_pos": 27, "end_pos": 61}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 95, "end_pos": 117}, {"end_pos": 174, "label_type": "解剖部位", "overlap": 0, "start_pos": 168}, {"end_pos": 184, "label_type": "解剖部位", "overlap": 0, "start_pos": 179}, {"end_pos": 202, "label_type": "解剖部位", "overlap": 0, "start_pos": 192}, {"end_pos": 217, "label_type": "解剖部位", "overlap": 0, "start_pos": 207}, {"end_pos": 233, "label_type": "解剖部位", "overlap": 0, "start_pos": 222}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 238, "end_pos": 246}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 251, "end_pos": 259}, {"end_pos": 351, "label_type": "药物", "overlap": 0, "start_pos": 349}, {"end_pos": 362, "label_type": "药物", "overlap": 0, "start_pos": 358}, {"end_pos": 391, "label_type": "解剖部位", "overlap": 0, "start_pos": 390}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 422, "end_pos": 430}]}
